PATENT CLAIM ANALYSIS

Application Number: 16059771
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "502000"]

Abstract:
Disclosed are methods and pharmaceutical compositions for modulating one or more steroidal receptor activities. The methods typically utilize and the pharmaceutical compositions typically include one or more substituted phenyl aziridine precursors, their respective aziridines, analogs thereof, derivatives thereof, or pharmaceutically acceptable salts thereof such as CpdA. The methods and compositions may be used for treating diseases, disorders, and conditions associated with glucocorticoid receptor activity, androgen receptor activity, or both, such as cancers, acne vulgaris, and alopecia.

Claim (Index 28):
A method of making a pharmaceutical composition for use in inhibiting prostate cancer cell growth in a patient having androgen-independent prostate cancer, the method comprising combining:\n (a) a therapeutically effective amount of a compound or a pharmaceutically acceptable salt thereof, the compound having a formula: wherein R is hydrogen or \u2014C(O)\u2014CH 3 , and X is a hydrogen or halogen; and (b) a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 96.0
- Lexical Diversity: 1.66667
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15346743', '13333543', '11730168', '15331751', '15331777']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7694355584153674
- 35 USC 102 Novelty (BERT): 0.5179921811163725
- Combined Prediction Score: 0.7442912206854679
- Mean Citation Score: 308.050116
- Max Citation Score: 325.84656
- Similarity Product: 255.7867808041764

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test